TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07593456: NST-SPARK Open-Label Phase 1 STTR (IGNITE)

Sponsor: North Shore Therapeutics, Inc. · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 30 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$5,354,400

Rescue Site Savings

+$3,530,800

Unlock Full NCT07593456 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07593456 Rescue Dossier →